Novartis announces global partnership with Amgen to develop and commercialize pioneering neuroscience treatments
- Details
- Category: Novartis

AstraZeneca and Valeant Pharmaceuticals to partner on brodalumab
- Details
- Category: AstraZeneca

Novo Nordisk plans 2 billion US dollar investment in new production facilities in Clayton, North Carolina and Måløv, Denmark
- Details
- Category: Novo Nordisk

AstraZeneca and Peregrine Pharmaceuticals to collaborate on immuno-oncology combination clinical trial
- Details
- Category: AstraZeneca

Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
- Details
- Category: Novartis

Sanofi, Evotec and Apeiron Biologics enter collaboration to develop novel small molecule immuno-oncology treatments
- Details
- Category: Sanofi

Boehringer Ingelheim and Circuit Therapeutics announce new collaboration to discover novel medicines for obesity
- Details
- Category: Boehringer Ingelheim

More Pharma News ...
- "Roche Continents" fosters innovation in science and art
- AstraZeneca and Heptares Therapeutics enter agreement to develop novel immuno-oncology treatments
- MedImmune and Mirati Therapeutics partner on immuno-oncology combination in lung cancer
- Pfizer and Synthon enter into U.S. commercialization agreement for potential generic treatment of multiple sclerosis
- Bristol-Myers Squibb establishes collaborative Immuno-Oncology Rare Population Malignancy (I-O RPM) program in the U.S.
- AstraZeneca and Isis Pharmaceuticals to discover and develop antisense drugs for cardiovascular, metabolic and renal diseases
- Merck announces application period for start-ups